PBK as a Potential Biomarker and Therapeutic Target for Metastatic Pheochromocytomas and Paragangliomas.
This study evaluates PDZ-binding kinase (PBK) as a biomarker and potential therapeutic target in pheochromocytomas and p...
This study evaluates PDZ-binding kinase (PBK) as a biomarker and potential therapeutic target in pheochromocytomas and p...
This study is a very large GWAS meta-analysis of thyroid diseases using genetic data from about 2.9 million individuals...
This article is a practical, technologist-focused overview of implementing theranostic care in nuclear medicine, emphasi...
This study retrospectively evaluated trans-submental endoscopic thyroidectomy (TSET) in 95 patients with benign thyroid...
This publication reviews the evolving role of molecular diagnostics in managing indeterminate thyroid nodules, a signifi...
The study analyzed thyroid cancer incidence and mortality data from SEER-22 and SEER-17 (2000-2019) to refine estimates...